A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation
Condition: Irritable Bowel Syndrome Characterized by Constipation Interventions: Drug: Linaclotide; Drug: Placebo Sponsors: Ironwood Pharmaceuticals, Inc.; Allergan Sales, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Constipation | Irritable Bowel Syndrome